Dominic Denk
Dominic Denk
1Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany
2Department of Medicine I, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany
3Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt am Main, Germany
1,2,3,
Anurag Singh
Anurag Singh
4Amazentis SA, Lausanne, Switzerland
4,
Herbert G Kasler
Herbert G Kasler
5GBG c/o GBG Forschungs GmbH, Neu-Isenburg, Germany
5,
Davide D’Amico
Davide D’Amico
4Amazentis SA, Lausanne, Switzerland
4,
Julia Rey
Julia Rey
5GBG c/o GBG Forschungs GmbH, Neu-Isenburg, Germany
5,
Lucía Alcober-Boquet
Lucía Alcober-Boquet
2Department of Medicine I, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany
2,
Johanna M Gorol
Johanna M Gorol
1Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany
1,
Christoph Steup
Christoph Steup
1Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany
2Department of Medicine I, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany
1,2,
Ritesh Tiwari
Ritesh Tiwari
5GBG c/o GBG Forschungs GmbH, Neu-Isenburg, Germany
5,
Ryan Kwok
Ryan Kwok
6Buck Institute for Research on Aging, Novato, CA USA
6,
Rafael J Argüello
Rafael J Argüello
7Aix Marseille Univ, CNRS, INSERM, CIML, Centre d’Immunologie de Marseille-Luminy, Marseille, France
7,
Julie Faitg
Julie Faitg
4Amazentis SA, Lausanne, Switzerland
4,
Kathrin Sprinzl
Kathrin Sprinzl
2Department of Medicine I, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany
2,
Stefan Zeuzem
Stefan Zeuzem
2Department of Medicine I, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany
8German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
2,8,
Valentina Nekljudova
Valentina Nekljudova
5GBG c/o GBG Forschungs GmbH, Neu-Isenburg, Germany
5,
Sibylle Loibl
Sibylle Loibl
5GBG c/o GBG Forschungs GmbH, Neu-Isenburg, Germany
5,
Eric Verdin
Eric Verdin
6Buck Institute for Research on Aging, Novato, CA USA
6,
Chris Rinsch
Chris Rinsch
4Amazentis SA, Lausanne, Switzerland
4,
Florian R Greten
Florian R Greten
1Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany
3Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt am Main, Germany
8German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
1,3,8,✉
1Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany
2Department of Medicine I, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany
3Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt am Main, Germany
4Amazentis SA, Lausanne, Switzerland
5GBG c/o GBG Forschungs GmbH, Neu-Isenburg, Germany
6Buck Institute for Research on Aging, Novato, CA USA
7Aix Marseille Univ, CNRS, INSERM, CIML, Centre d’Immunologie de Marseille-Luminy, Marseille, France
8German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
Subject terms: Lymphocytes, Inflammation, Ageing
© The Author(s) 2026
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.